Related Experiment Video
Updated: Jun 29, 2026
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B
Xin-Bo Xue1, Kun Chen, Cong-Jun Wang
1Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. xiangfanck@163.com.
Background:
Melanoma differentiation associated gene-7 (mda-7) is a novel tumor suppressor gene, which has suppressor activity in a broad spectrum of human cancer cells both in vitro and in vivo through activation of various intracellular signaling pathways. In this study, we investigated the potential effect of mda-7 on human hepatocellular carcinoma (HCC) in vitro.
Methods:
Cells from the human HCC cell line Hep3B and the human liver cell line L-02 were assigned to three groups. One was cultured in Dulbecco's modified Eagle's medium without serum (control). The others were transfected with adenovirus expressing the mda-7 gene (Ad.mda-7) or adenovirus vector serving as negative control (Ad.vec). The expression of MDA-7 and Bcl-2 proteins in Hep3B and L-02 cells was confirmed by the reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay. The methyl thiazolyl tetrazolium colorimetric assay and flow cytometry were used to assess tumor cell proliferation and the cell cycle. Hoechst and Annexin-V/propidium iodide staining were used to study mda-7 gene expression in Hep3B and L-02 cells. The expression of MDA-7, Bcl-2 and Bax proteins were detected by Western blotting.
Results:
The mda-7 gene was expressed in Hep3B and L-02 cells. The protein concentrations of MDA-7 in supernatants were 790 and 810 pg/ml, respectively. mda-7 induced Hep3B growth suppression and apoptosis, compared with Ad.mda-7 and control (P<0.01). In addition, cell block in G2/M was identified by exposure of HCC cells to secreted MDA-7 protein, but this was not found in L-02. The gene expression of Bcl-2 was markedly decreased in Hep3B but not in L-02.
Conclusions:
mda-7 selectively induces growth inhibition and apoptosis in the HCC cell line Hep3B but not in the normal liver cell line L-02 via downregulating the anti-apoptosis protein Bcl-2. It could be an ideal gene for gene therapy in HCC.
Insights
Melanoma differentiation associated gene-7 (mda-7) selectively inhibits hepatocellular carcinoma (HCC) cell growth and induces apoptosis. This tumor suppressor gene downregulates Bcl-2, offering potential for HCC gene therapy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Melanoma differentiation associated gene-7 (mda-7) is a novel tumor suppressor with broad-spectrum anticancer activity.
- Its intracellular signaling pathways are known to impact various cancer types.
- This study investigates the in vitro effects of mda-7 on human hepatocellular carcinoma (HCC).
Purpose of the Study:
- To evaluate the potential of mda-7 as a therapeutic agent for HCC.
- To determine the specific mechanisms by which mda-7 affects HCC cells.
- To assess the selectivity of mda-7's action on cancer versus normal liver cells.
Main Methods:
- Human HCC (Hep3B) and normal liver (L-02) cell lines were used.
- Cells were transfected with adenovirus expressing mda-7 (Ad.mda-7) or a control vector (Ad.vec).
- Gene and protein expression (MDA-7, Bcl-2, Bax), cell proliferation, cell cycle, and apoptosis were analyzed using RT-PCR, ELISA, MTT assay, flow cytometry, and Western blotting.
Main Results:
- mda-7 gene and protein were successfully expressed in both Hep3B and L-02 cells.
- Ad.mda-7 significantly suppressed Hep3B cell growth and induced apoptosis compared to controls (P<0.01).
- HCC cells exhibited G2/M cell cycle arrest, and Bcl-2 expression was downregulated in Hep3B cells, but not in L-02 cells.
Conclusions:
- mda-7 selectively induces growth inhibition and apoptosis in HCC cells (Hep3B) but not normal liver cells (L-02).
- The mechanism involves downregulating the anti-apoptotic protein Bcl-2.
- mda-7 shows promise as an ideal candidate for HCC gene therapy.
